We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLYG icon
4876
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.23B
$6K ﹤0.01%
82
NSLR
4877
Neostellar Capital Corp
NSLR
$287M
$6K ﹤0.01%
1,581
-1,704
-52% -$6.55K
STPZ icon
4878
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
$6K ﹤0.01%
125
-77
-38% -$3.87K
STRR
4879
DELISTED
Star Equity Holdings
STRR
$6K ﹤0.01%
1,232
-5
-0.4% -$22
SYBX
4880
DELISTED
Synlogic
SYBX
$6K ﹤0.01%
684
-377
-36% -$4.48K
SYM icon
4881
Symbotic
SYM
$5.35B
$6K ﹤0.01%
+251
New +$4.2K
TDTT icon
4882
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
$6K ﹤0.01%
261
-10
-4% -$237
TOMZ icon
4883
TOMI Environmental Solutions
TOMZ
$12.9M
$6K ﹤0.01%
2,831
-4
-0.1% -$8
TSAT icon
4884
Telesat
TSAT
$934M
$6K ﹤0.01%
682
-461
-40% -$3.95K
TSHA icon
4885
Taysha Gene Therapies
TSHA
$1.92B
$6K ﹤0.01%
7,255
-3,763
-34% -$4.86K
UBCP icon
4886
United Bancorp
UBCP
$89.2M
$6K ﹤0.01%
380
+197
+108% +$2.86K
TONX
4887
TON Strategy Co
TONX
$158M
$6K ﹤0.01%
6
+1
+20% +$1.3K
VYGR icon
4888
Voyager Therapeutics
VYGR
$197M
$6K ﹤0.01%
748
-5,748
-88% -$45.7K
WHG icon
4889
Westwood Holdings Group
WHG
$183M
$6K ﹤0.01%
+522
New +$6.42K
WINT
4890
DELISTED
Windtree Therapeutics
WINT
$6K ﹤0.01%
+1
New +$6.7K
WNEB icon
4891
Western New England Bancorp
WNEB
$282M
$6K ﹤0.01%
780
-3,369
-81% -$31.9K
WPRT
4892
Westport Fuel Systems
WPRT
$34.6M
$6K ﹤0.01%
625
+196
+46% +$2.01K
XSVM icon
4893
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$675M
$6K ﹤0.01%
+140
New +$6.73K
VSTD
4894
DELISTED
Vestand Inc
VSTD
$6K ﹤0.01%
1,555
+1,256
+420% +$5.08K
ABTC
4895
American Bitcoin Corp
ABTC
$505M
$6K ﹤0.01%
5
RPT
4896
Rithm Property Trust
RPT
$99.9M
$6K ﹤0.01%
163
+119
+270% +$5.65K
TECX
4897
Tectonic Therapeutic
TECX
$720M
$6K ﹤0.01%
530
-732
-58% -$10.2K
ORKA
4898
Oruka Therapeutics
ORKA
$7.11B
$6K ﹤0.01%
249
+126
+102% +$3.32K
RIME
4899
Algorhythm Holdings
RIME
$6.98M
$6K ﹤0.01%
19
+5
+36% +$3.47K
HURA
4900
TuHURA Biosciences
HURA
$149M
$6K ﹤0.01%
51
+35
+219% +$6.75K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.